Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Responsible business can drive radical innovation in healthcare

29.06.2006
Speech by top executive and newly endowed professor Lise Kingo

The healthcare sector is ripe for radical innovation, and the pharmaceutical industry can lead the way if it rethinks its way of engaging with stakeholders. Success depends on three factors: operating according to a new, broader business principle, fostering partnerships and taking on a greater social responsibility. The pharmaceutical industry can rebuild society’s trust if it begins to see corporate responsibility as an opportunity for innovation and not simply as a form of risk management. That is the argument which Professor Lise Kingo will put forward on Wednesday 28 June, in a speech to mark her appointment as Endowed Professor of Sustainability and Innovation in Health and Life Sciences-Based Companies in the Faculty of Medicine and the Faculty of Earth and Life Sciences at VU Amsterdam.

Lise Kingo is a member of the executive management of the Danish healthcare company Novo Nordisk. In her speech, entitled "Corporate responsibility as a driver of innovation in healthcare", she calls upon her own industry to respond to social change and to take public criticism seriously. The industry’s future is at stake: it is criticized for lack of innovation, high costs and for neglecting real needs, in particular the need to combat diseases in developing countries. Its business practices are under scrutiny for lack of transparency, and stakeholders want to see evidence of ethical conduct in everything from clinical trials and animal experimentation to marketing and sales.

According to Lise Kingo, this situation highlights the need for a new and broader business model for the pharmaceutical industry. In fact, she argues, it is high time to rethink how we look at business design for the healthcare sector as a whole. For the industry to be sustainable, it needs to understand its role and responsibility in society, to learn with its stakeholders (including patients’ associations, doctors, insurers and NGOs), and to think beyond its own short-term interests.

Lise Kingo highlights signs of positive change that might help win back public confidence and renew the industry’s long-term business prospects. Many pharmaceutical companies embrace corporate responsibility and report on it. Several large pharmaceutical companies are now listed in the Dow Jones Sustainability Index. Novo Nordisk heads the list of firms in the healthcare sector. Kingo has been the driving force behind the company’s strategic approach to corporate responsibility, and in her speech she uses this to illustrate how and why corporate responsibility can be part of core business.

The healthcare challenges are illustrated by the need for improved diabetes care, which is the focus for Novo Nordisk. Prevention, early diagnosis and effective treatment not only improve the health of diabetes patients, but also help alleviate the increasing burden on the healthcare system and society as a whole caused by the epidemic growth in this disease. Examples from Novo Nordisk’s business approach in the Netherlands and its long-standing collaboration with VU Amsterdam show how better results can be achieved in practice by successful collaboration and new models of engagement.

As part of Kingo’s chair at VU Amsterdam, a research programme will further explore such opportunities for innovation in the healthcare sector. It will also seek to identify how corporate responsibility can be a driver for change in a range of business sectors.

Tanja Terpstra | alfa
Further information:
http://www.novonordisk.com
http://www.vu.nl

More articles from Health and Medicine:

nachricht Electrical 'switch' in brain's capillary network monitors activity and controls blood flow
27.03.2017 | Larner College of Medicine at the University of Vermont

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>